投融资数据库
免费查数据
注册送3天会员
首页>投融资
MRM Health
B轮
MRM Health NV is a biotechnology company focused on the discovery and development of innovative therapeutics based on the human microbiome.In February 2021, MRM Health NV collaborated with DuPont Nutrition & Biosciences.In February 2020, MRM Health entered into a collaboration with Dupont Nutrition Biosciences Aps for the discovery and development of innovative therapies for metabolic diseases, using MRM health's simulator of the human intestinal microbial ecosystem (SHIME) technology platform. MRM Health had raised more than EURO 14 million (US $15.43 million) to advance its in-house clinical and preclinical development programs in the field of microbiome-based therapeutics and strengthens its partnership with VIB, KU Leuven and Ghent University.In February 2020 MRM Health also announced a business collaboration with DuPont Nutrition & Biosciences
基本信息
-
公司全称MRM Health
-
类型生物制药研发商
-
产业领域医药研发/制造、化学&生物药
-
公司人数15~50人
-
地址Technologiepark 94 GENT OOST-VLAANDEREN 9052; BE;
-
联系电话3292411188
-
邮箱info@mrmhealth.com
-
成立时间2020-01-01
投融资
-
2025-09-04
-
2020-04-13
相关投融资企业
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
收并购
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发新的癌症疗法,旨在通过针对失调转录的精确药物策略来改变患者的预后。